Advanz Pharma Agrees Sale In Largest European Deal Since COVID-19 Pandemic

Jefferies: ‘Deal Signals A Reduction Of Brexit Risk And A Recovery In The Debt Markets’

 
• By Dean Rudge

Three years after rebranding from Concordia, Advanz Pharma is to be swallowed up by European-focused private equity Nordic Capital.

Dollars
Nordic Capital 'is committed to investing in the growth of the business going forward.' • Source: Shutterstock

More from Deals

More from Business